UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549

                                    FORM 8-K


                                 CURRENT REPORT

                     Pursuant to Section 13 or 15(d) of the
                         Securities Exchange Act of 1934

     Date of Report (date of earliest event reported): February 24, 2017


                               CEL-SCI CORPORATION
              ---------------------------------------------------
             (Exact name of Registrant as specified in its charter)



       Colorado                       01-11889                  84-0916344
 --------------------            -------------------         ----------------
(State or other jurisdiction    (Commission File No.)       (IRS Employer
of incorporation)                                            Identification No.)


                         8229 Boone Boulevard, Suite 802
                             Vienna, Virginia 22182
              ---------------------------------------------------
          (Address of principal executive offices, including Zip Code)



       Registrant's telephone number, including area code: (703) 506-9460

                                       N/A
              ---------------------------------------------------
          (Former name or former address if changed since last report)

<PAGE>

Item 3.01.  Other Events.

     On December 9, 2016,  the  Company  received  notice from the NYSE MKT (the
"Exchange")  indicating  that the Company  was not in  compliance  with  Section
1003(a) of the Exchange's  continued listing standards in the Company Guide. The
Company was afforded the opportunity to submit a plan to regain compliance,  and
on January 9, 2017 the Company submitted its plan to the Exchange.

     On February  24, 2017,  the Exchange  notified the Company that it accepted
the Company's plan of compliance and granted the Company an extension until June
11, 2018 to regain compliance with the continued listing standards.  The Company
will be subject to periodic review during the extension period.  Failure to make
progress  consistent  with the plan or to regain  compliance  with the continued
listing standards by the end of the extension period could result in the Company
being delisted from the NYSE MKT.

     On February 27, 2017,  the Company  issued a press release  announcing  its
receipt from the Exchange of its acceptance of the Company's plan of compliance.
The full text of this press release is attached as Exhibit 99.

Item 9.01.  Financial Statements anf Exhibits.

Exhibit     Description
-------     -----------

 99         Press Release dated February 27, 2017



                                       2
<PAGE>




                                   SIGNATURES

     Pursuant to the  requirements  of the Securities  Exchange Act of 1934, the
registrant  has duly  caused  this  report  to be  signed  on its  behalf by the
undersigned hereunto duly authorized.


Date:  February 27, 2017                     CEL-SCI CORPORATION



                                         By: /s/ Patricia B. Prichep
                                             ---------------------------------
                                             Patricia B. Prichep,
                                             Senior Vice President of Operations
[{"type": "8-K", "sequence": "1", "filename": "form8kitem301nyse2-17.txt", "description": "8-K ITEM 3.01", "secsgml_size_bytes": 3404}]
{"company-data": {"conformed-name": "CEL SCI CORP", "cik": "0000725363", "assigned-sic": "2836", "irs-number": "840916344", "state-of-incorporation": "CO", "fiscal-year-end": "0930"}, "filing-values": {"form-type": "8-K", "act": "34", "file-number": "001-11889", "film-number": "17643506"}, "business-address": {"street1": "8229 BOONE BLVD .", "street2": "SUITE 802", "city": "VIENNA", "state": "VA", "zip": "22182", "phone": "7035069460"}, "mail-address": {"street1": "8229 BOONE BLVD.", "street2": "SUITE 802", "city": "VIENNA", "state": "VA", "zip": "22182"}, "former-company": {"former-conformed-name": "INTERLEUKIN 2 INC", "date-changed": "19880317"}}
UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549

                                    FORM 8-K

                                 CURRENT REPORT

                     Pursuant to Section 13 or 15(d) of the
                         Securities Exchange Act of 1934

     Date of Report (date of earliest event reported): February 24, 2017

                               CEL-SCI CORPORATION
              ---------------------------------------------------
             (Exact name of Registrant as specified in its charter)

       Colorado                       01-11889                  84-0916344
 --------------------            -------------------         ----------------
(State or other jurisdiction    (Commission File No.)       (IRS Employer
of incorporation)                                            Identification No.)

                         8229 Boone Boulevard, Suite 802
                             Vienna, Virginia 22182
              ---------------------------------------------------
          (Address of principal executive offices, including Zip Code)

       Registrant's telephone number, including area code: (703) 506-9460

                                       N/A
              ---------------------------------------------------
          (Former name or former address if changed since last report)
Item 3.01.  Other Events.

     On December 9, 2016,  the  Company  received  notice from the NYSE MKT (the
"Exchange")  indicating  that the Company  was not in  compliance  with  Section
1003(a) of the Exchange's  continued listing standards in the Company Guide. The
Company was afforded the opportunity to submit a plan to regain compliance,  and
on January 9, 2017 the Company submitted its plan to the Exchange.

     On February  24, 2017,  the Exchange  notified the Company that it accepted
the Company's plan of compliance and granted the Company an extension until June
11, 2018 to regain compliance with the continued listing standards.  The Company
will be subject to periodic review during the extension period.  Failure to make
progress  consistent  with the plan or to regain  compliance  with the continued
listing standards by the end of the extension period could result in the Company
being delisted from the NYSE MKT.

     On February 27, 2017,  the Company  issued a press release  announcing  its
receipt from the Exchange of its acceptance of the Company's plan of compliance.
The full text of this press release is attached as Exhibit 99.

Item 9.01.  Financial Statements anf Exhibits.

Exhibit     Description
-------     -----------

 99         Press Release dated February 27, 2017

                                       2
SIGNATURES

     Pursuant to the  requirements  of the Securities  Exchange Act of 1934, the
registrant  has duly  caused  this  report  to be  signed  on its  behalf by the
undersigned hereunto duly authorized.

Date:  February 27, 2017                     CEL-SCI CORPORATION

                                         By: /s/ Patricia B. Prichep
                                             ---------------------------------
                                             Patricia B. Prichep,
                                             Senior Vice President of Operations